Physician

Edward Mcdermott Mcgill, M.D.

According to 2025 Medicare claims, Edward Mcgill, M.D. (NPI: 1629033972) practices ophthalmology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF THE MIDLANDS PC (NPI: 1346338092; TIN: 470628387) and primary practice location at 68114-4762.

Mcgill's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,054 traditional Medicare patients, billed 46,485 HCPCS/CPT codes, and received $2,093,991 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 1,479 prescription claims across 298 beneficiaries totaling $31,128 in drug costs, led by Rhopressa (Netarsudil Mesylate). Open Payments data shows 1 records totaling $139. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $99,039 to $31,128. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.1M2015 Medicare payment: $1,659,237 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,600,287 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,538,467 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,415,187 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,434,714 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,461,153 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,418,657 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,370,187 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,680,965 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,093,991 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,24112,678$1,659,237
20161,30112,749$1,600,287
20171,29811,465$1,538,467
20181,24410,612$1,415,187
20191,16910,163$1,434,714
20201,0579,737$1,461,153
20211,10810,034$1,418,657
20221,09510,536$1,370,187
20231,03421,008$1,680,965
20241,05446,485$2,093,991

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$51K$102K2015 Drug cost: $99,039 (USD; Tot_Drug_Cst)2016 Drug cost: $102,236 (USD; Tot_Drug_Cst)2017 Drug cost: $95,793 (USD; Tot_Drug_Cst)2018 Drug cost: $57,000 (USD; Tot_Drug_Cst)2019 Drug cost: $72,339 (USD; Tot_Drug_Cst)2020 Drug cost: $53,166 (USD; Tot_Drug_Cst)2021 Drug cost: $51,890 (USD; Tot_Drug_Cst)2022 Drug cost: $39,954 (USD; Tot_Drug_Cst)2023 Drug cost: $46,834 (USD; Tot_Drug_Cst)2024 Drug cost: $31,128 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153321,117$99,039
20163131,147$102,236
20172411,090$95,793
20182421,165$57,000
20192401,118$72,339
20202311,014$53,166
20212411,017$51,890
20222291,051$39,954
20232601,167$46,834
20242981,479$31,128

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system223223$96
92014Established patient complete exam of visual system648755$80
67028Injection of drug into eye2781,180$80
92012Established patient problem focused exam of visual system372902$60
92134Imaging of retina8812,594$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RhopressaNetarsudil Mesylate14540$4,492
Prednisolone AcetatePrednisolone Acetate1114,708$3,708
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat22314,599$3,399
LatanoprostLatanoprost48819,988$2,829
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1252,728$1,527

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$139Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Edward Mcdermott Mcgill, M.D.?

Tedicare shows public-source Medicare data for Edward Mcdermott Mcgill, M.D. (NPI 1629033972), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward Mcdermott Mcgill, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Edward Mcdermott Mcgill, M.D.?

Edward Mcdermott Mcgill, M.D. is linked to RETINA CONSULTANTS OF THE MIDLANDS PC (billing NPI 1346338092) in the available physician profile data.

Does Edward Mcdermott Mcgill, M.D. have Open Payments data?

Edward Mcdermott Mcgill, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.